Literature DB >> 25834535

Bone turnover biomarkers in obese postmenopausal Saudi women with type-II diabetes mellitus.

Nada M Alselami1, Amani F H Noureldeen2, Maryam A Al-Ghamdi1, Jalaluddin A Khan1, Said S Moselhy2.   

Abstract

BACKGROUND: There is a high prevalence of diabetes mellitus type-2 (T2DM) and osteoporosis are problems worldwide. In this study, we evaluated the correlation between T2DM and bone turnover in diabetic obese postmenopausal Saudi women. SUBJECTS AND METHODS: The present study included total of 65 T2-DM obese postmenopausal Saudi women, (36 uncontrolled, 29 controlled). The following serum biochemical parameters were evaluated [fasting blood glucose (FBG), total calcium (Ca), phosphorus (Pi), parathyroid hormone (PTH), 1,25-(OH)2 Vitamin D3, osteocalcin (OC), procollagen (PICP) and cathepsin k (Cath K)].
RESULTS: Serum OC levels were significantly decreased in diabetic obese postmenopausal group compared to their respective healthy group (P < 0.004). PICP and Cath K were significantly elevated in diabetic postmenopausal group compared to the healthy group (P < 0.024 &amp; 0.001). A significant elevation in 1,25(OH)2 Vitamin D3, Ca and Pi levels in diabetic obese postmenopausal patients group compared to the healthy group. However, a non-significant changes was observed in serum PTH level between different groups.
CONCLUSION: In this study, the changes in the biochemical parameters and bone turnover markers in obese women are strong risk factors for diabetes development that may contribute to osteopenia and osteoporosis. The study showed the strong effect of T2DM on biochemical markers of bone turnover in obese postmenopausal Saudi women.

Entities:  

Keywords:  Bone markers; Diabetes mellitus type-2; Postmenopausal

Mesh:

Substances:

Year:  2015        PMID: 25834535      PMCID: PMC4370142          DOI: 10.4314/ahs.v15i1.12

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  13 in total

1.  25-OH vitamin D: is it the universal panacea for metabolic syndrome and type 2 diabetes?

Authors:  Kwame Osei
Journal:  J Clin Endocrinol Metab       Date:  2010-09       Impact factor: 5.958

Review 2.  Sex steroids and bone.

Authors:  J E Compston
Journal:  Physiol Rev       Date:  2001-01       Impact factor: 37.312

3.  Population-based epidemiological study of the prevalence of overweight and obesity in Saudi Arabia, regional variation.

Authors:  A R Al-Nuaim
Journal:  Ann Saudi Med       Date:  1997-03       Impact factor: 1.526

4.  Prevalence of overweight and obesity in diabetic and non-diabetic Saudis.

Authors:  M A el-Hazmi; A S Warsy
Journal:  East Mediterr Health J       Date:  2000 Mar-May       Impact factor: 1.628

5.  Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells.

Authors:  B Maestro; J Campión; N Dávila; C Calle
Journal:  Endocr J       Date:  2000-08       Impact factor: 2.349

Review 6.  Vitamin D and diabetes.

Authors:  Anastassios G Pittas; Bess Dawson-Hughes
Journal:  J Steroid Biochem Mol Biol       Date:  2010-03-18       Impact factor: 4.292

Review 7.  Vitamin D and diabetes.

Authors:  Tatiana Takiishi; Conny Gysemans; Roger Bouillon; Chantal Mathieu
Journal:  Endocrinol Metab Clin North Am       Date:  2010-06       Impact factor: 4.741

Review 8.  Bone health in diabetes: considerations for clinical management.

Authors:  Silvano Adami
Journal:  Curr Med Res Opin       Date:  2009-05       Impact factor: 2.580

9.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

Authors:  Sarah Wild; Gojka Roglic; Anders Green; Richard Sicree; Hilary King
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

10.  Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study.

Authors:  Jøran Hjelmesaeth; Dag Hofsø; Erlend T Aasheim; Trond Jenssen; Johan Moan; Helle Hager; Jo Røislien; Jens Bollerslev
Journal:  Cardiovasc Diabetol       Date:  2009-02-03       Impact factor: 9.951

View more
  2 in total

1.  From Ebola in the slums of East and West Africa to NCDs, mental, child and reproductive health.

Authors:  James K Tumwine
Journal:  Afr Health Sci       Date:  2015-03       Impact factor: 0.927

2.  Markers of Bone Metabolism in Patients With Chronic Pancreatitis and Pancreatic Ductal Adenocarcinoma.

Authors:  Raffaele Pezzilli; Gian Vico Melzi d'Eril; Alessandra Barassi
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.